ASTRO 2017 Annual Meeting


September 24-27 marked the annual American Society for Radiation Oncology (ASTRO) meeting. Radiation oncologists came together in San Diego, California to discuss the latest research and findings related to radiation therapy. Journal of Clinical Pathways has provided some of the most relevant discussions from this meeting.



Liquid Biopsy Identifies Poor Prognosis in Patients With NSCLC

A liquid biopsy that measures circulating lung tumor DNA at the end of treatment identifies patients with early non-small cell lung cancer with a poor prognosis.


Psychological Distress Predicts Treatment Adherence, Hospital Admission During Radiation

Almost 50% of patients with cancer who experience severe distress miss at least one radiation therapy appointment and are admitted to the hospital during their treatment.

Read More


Management of DLBCL Subtypes With Consolidative Radiation Therapy

Consolidative radiation therapy may provide a significant benefit to patients with specific subtypes of diffuse large B-cell lymphoma.

Read More


Survey: Patients With Breast Cancer Surprised by Side Effects of Radiation Therapy

A recent survey found that 90% of patients treated with radiation therapy for breast cancer found their experiences to be less “scary” than anticipated.

Read More







Pediatric Progressive or Relapsed Hodgkin Lymphoma May Be Treated With Radiotherapy

Progressive or relapsed Hodgkin lymphoma has demonstrated responsiveness to salvage radiotherapy in pediatric patients.

Read More



High-Dose Radiation Plus Immunotherapy Halts Tumor Growth in Advanced Cancers

Many patients with stage IV metastatic cancer achieve stable disease after treatment with radiation therapy and immunotherapy.

Read More